October 19, 2018
“They possess a gift or two; one of them is this, they have the power to make a wish come true; fate comes in and sees you through” …
In this sector, it made no difference what you held
Wish for an algorithmic rule with a re-programming request
I post about “indication intelligence” devoting my time to collection and analysis of information in the perception of sector vulnerabilities and strengths – it’s more than opinion, some facts in evidence need to be recognized!
You could have been reading – SUBSCRIBE!
October 19, 2018
Volume, share pricing, offerings, enrollments issues and clinical results are indications of volatility - how do they measure value on a daily basis!
Review daily indicators, factors and trend lines; pre-open indications, closing bell results, volatility metrics, weekly and monthly advancers versus decliners and more ...
Does Q3's momentum’s and voloatility indicate pricing performance for Q4 and FY18’s end?
October 19, 2018
When you wish upon a session, makes no difference which … stock you held
RMi puts the facts into evidence for the metrics to speak; my motto, “Never leave an investor uninformed”!
When is it wrong to be right so often? Your portfolio should be profiting from RMi’s analysis!
October 19, 2018
Volume, share pricing, offerings, enrollments issues and clinical results are indications of volatility - how do they measure value on a daily basis! Review daily indicators, factors and trend lines; pre-open indications, closing bell results, volatility metrics, weekly and monthly advancers versus decliners and more ... Does Q3's momentum’s and voloatility indicate pricing performance for Q4 and FY18’s end? http://www.regmedinvestors.com/create-account
October 14, 2018
Shares of VSTM closed down $0.58 or -9.31%% to $5.65 due to its selling millions worth of (unsecured) convertible notes due 2048; that might seem like a low interest rate to be paying for such a long term, but the note holders can convert the notes into 139.5771 shares for every $1,000 principal amount of the notes they own.
October 10, 2018
BOLD closed down -$6.88or -18.73% to $29.83 after Tuesday's +$0.37 to $36.70. With a 52 week change of +32.63% with ... ... 37.33 M shares outstanding and a float of 29.2 M shares – issue a -8.43% or 1.97 M share short ratio.
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.
October 19, 2018
RegMed Investors’ (RMi): The sector’s Q3 performance - it's that time again!
October 19, 2018
RegMed Investors’ (RMi) closing bell: Another session of reversals reminds us that Friday is the anniversary of the 1987 stock-market crash
October 19, 2018
RegMed Investors’ (RMi) pre-open: when you wish upon a stock
October 18, 2018
RegMed Investors’ (RMi) closing bell: tick, tick and another sector slip and fall
October 18, 2018
RegMed Investors’ (RMi) pre-open: after jumping and dumping, short hops should be the session’s mode
October 17, 2018
RegMed Investors’ (RMi) closing bell: it ain’t over after another volatile trading session
October 17, 2018
RegMed Investors’ (RMi) pre-open: sector timing can be a short-term portfolio cash builder
October 16, 2018
RegMed Investors’ (RMi) closing bell: the thundering indexes rolled-up the oversold
October 16, 2018
RegMed Investors’ (RMi) pre-open: the IBB has risen +0.79%
October 15, 2018
RegMed Investors’ (RMi) pre-open: there’s a share price for everything
© 2018 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
